NO955326L - Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse - Google Patents

Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO955326L
NO955326L NO955326A NO955326A NO955326L NO 955326 L NO955326 L NO 955326L NO 955326 A NO955326 A NO 955326A NO 955326 A NO955326 A NO 955326A NO 955326 L NO955326 L NO 955326L
Authority
NO
Norway
Prior art keywords
group
therapeutic use
preparation
isoquinoline derivatives
alkyl group
Prior art date
Application number
NO955326A
Other languages
English (en)
Other versions
NO955326D0 (no
Inventor
Mireille Sevrin
Benoit Marabout
Jacques Froissant
Catherine Guinot
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO955326D0 publication Critical patent/NO955326D0/no
Publication of NO955326L publication Critical patent/NO955326L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Forbindelser med generell formel (I) (D hvor X representerer et hydrogenatom, et halogenatom, en trifluormetylgruppe, en alkylgruppe eller en eller to alkoksy- grupper, Y representerer et hydrogenatom, et halogenatom, en alkylgruppe eller en alkoksygruppe, RL representerer en alkyl- gruppe og R representerer en hydroksygruppe, en metoksygruppe, en etoksygruppe eller en gruppe med generell formel NR2R3 hvor R2 og R3 hver representerer et hydrogenatom eller en alkylgruppe. Forbindelsene har terapeutisk anvendelse.
NO955326A 1994-12-29 1995-12-28 Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse NO955326L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415837A FR2728900B1 (fr) 1994-12-29 1994-12-29 Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO955326D0 NO955326D0 (no) 1995-12-28
NO955326L true NO955326L (no) 1996-07-01

Family

ID=9470390

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955326A NO955326L (no) 1994-12-29 1995-12-28 Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse

Country Status (22)

Country Link
US (1) US5665733A (no)
EP (1) EP0719764B1 (no)
JP (1) JPH08239365A (no)
KR (1) KR960022472A (no)
CN (1) CN1131150A (no)
AR (1) AR002016A1 (no)
AT (1) ATE172966T1 (no)
AU (1) AU698595B2 (no)
BR (1) BR9506106A (no)
CA (1) CA2166234A1 (no)
CO (1) CO4700298A1 (no)
CZ (1) CZ348995A3 (no)
DE (1) DE69505780D1 (no)
FI (1) FI956298A (no)
FR (1) FR2728900B1 (no)
HU (1) HU215394B (no)
IL (1) IL116590A0 (no)
NO (1) NO955326L (no)
NZ (1) NZ280765A (no)
PL (1) PL312079A1 (no)
SK (1) SK165795A3 (no)
ZA (1) ZA9511046B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750427B1 (fr) * 1996-06-28 1998-08-07 Synthelabo Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
FR2772758B1 (fr) * 1997-12-22 2000-02-04 Synthelabo Derives de 1-oxo-1,2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
DE60335911D1 (de) * 2002-12-20 2011-03-10 Daiichi Sankyo Co Ltd Isochinolinonderivate und deren verwendung als medikamente
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
PL2064185T3 (pl) * 2006-08-10 2011-11-30 Ferrer Int Związki 1H-chinolin-4-onowe z powinowactwem do receptora GABA, sposoby wytwarzania, zastosowanie i kompozycje
EP1886996A1 (en) * 2006-08-10 2008-02-13 Ferrer Internacional, S.A. 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions
WO2010083436A1 (en) 2009-01-15 2010-07-22 Rutgers, The State University Of New Jersey Benzo [c] phenanthridines as antimicrobial agents
US20120059026A1 (en) 2009-04-30 2012-03-08 University Of Medicine And Dentistry Of New Jersey Antimicrobial agents
FR2956816B1 (fr) * 2010-03-01 2012-05-18 Univ Joseph Fourier Utilisation de quinolones pour la preparation de medicaments, nouvelles quinolones et leur procede de synthese
US8933096B2 (en) 2010-06-09 2015-01-13 Rugers, The State University of New Jersey Antimicrobial agents
WO2011163610A2 (en) 2010-06-25 2011-12-29 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
AU2013235038A1 (en) 2012-03-21 2014-10-09 Malvika Kaul Antimicrobial agents
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
JP2019507801A (ja) 2016-02-25 2019-03-22 タクシス ファーマシューティカルズ， インコーポレイテッド 合成プロセス及び中間体
CA3058183A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
TW202202495A (zh) * 2020-03-26 2022-01-16 匈牙利商羅特格登公司 作為ｇａｍｍａ－胺基丁酸Ａ受體次單元ａｌｐｈａ ５受體調節劑之㖠啶及吡啶并〔３，４－ｃ〕嗒𠯤衍生物
US20240043418A1 (en) * 2020-03-26 2024-02-08 Richter Gedeon Nyrt. 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators

Also Published As

Publication number Publication date
PL312079A1 (en) 1996-07-08
FR2728900B1 (fr) 1997-01-31
SK165795A3 (en) 1996-07-03
BR9506106A (pt) 1997-12-23
HU9503848D0 (en) 1996-02-28
DE69505780D1 (de) 1998-12-10
CA2166234A1 (en) 1996-06-30
AR002016A1 (es) 1998-01-07
US5665733A (en) 1997-09-09
KR960022472A (ko) 1996-07-18
NZ280765A (en) 1996-08-27
ZA9511046B (en) 1996-07-11
HU215394B (hu) 1998-12-28
ATE172966T1 (de) 1998-11-15
AU4071295A (en) 1996-07-04
HUT74187A (en) 1996-11-28
IL116590A0 (en) 1996-03-31
EP0719764A1 (fr) 1996-07-03
FR2728900A1 (fr) 1996-07-05
AU698595B2 (en) 1998-11-05
CO4700298A1 (es) 1998-12-29
EP0719764B1 (fr) 1998-11-04
CZ348995A3 (en) 1996-07-17
FI956298A (fi) 1996-06-30
NO955326D0 (no) 1995-12-28
FI956298A0 (fi) 1995-12-28
JPH08239365A (ja) 1996-09-17
CN1131150A (zh) 1996-09-18

Similar Documents

Publication Publication Date Title
NO955326L (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
CA2161542A1 (en) Novel 5-Pyrrolyl-2-Pyridylmethylsulfinyl Benzimidazole Derivatives
ATE117681T1 (de) Chinolinderivate, ihre herstellung und verwendung.
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
FI882590A0 (fi) Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
ATE104965T1 (de) Chinolinderivate, ihre herstellung und verwendung.
FI893901A0 (fi) Menetelmä tetrasyklisten masennuslääkkeiden valmistamiseksi
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
NO991581L (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
DE69708484D1 (de) Pyridinderivate,als Arzneimittel zur Behandlung von Geschwüren und als antibakterielle Mittel
YU166291A (sh) Indenoindol jedinjenja
FR2529891B1 (no)
ES8604912A1 (es) Procedimiento de preparacion de nuevos derivados de (arilpi-peraziniletilaminoetoxi)-4 fenol
NO914192L (no) 8-azabicyklo(3.2.1)oktylalkylthiazolidinoner, fremgangsmaate for fremstilling og anvendelse som medikamenter
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
TR199801683A2 (xx) Yeni �re t�revleri.
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
TR200000114T2 (tr) Farnesil protein transferazı'nın önlenmesine mahsus benzo(5,6)siklohepta(1,2-B)piridin türevleri.
AU586255B2 (en) Substituted pyridine-1-oxides
DK104488A (da) Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
DK1056769T3 (da) 15-methyl-cyclopropanosteroider og fremgangsmåde til deres fremstilling